COVID-19 and mutations a threat level assessment
Short Communication
[키워드] African
B.1.1.7
B.1.351
B.1.526
cause
concerning
COVID-19
COVID-19 Virus variants
defined
DNA
E484K
effective
Efficacy
English
Genome
genotypic
Health
immune evasion
Immunity
immunized
implicated
individual
International
Mutation
mutations
N501Y
North America
offer
P.1
pathogen
phenotypic
reduced
risk
RNA sequence
SARS-CoV-2 B.1.1.7 variant
SARS-CoV-2 B.1.351
SARS-CoV-2 variants
SARS-CoV-2 virus
severe infections
South
survival
the SARS-CoV-2
vaccination
Vaccine
variant
variants
virulence
virus
[DOI] 10.3126/nje.v11i1.35659 PMC 바로가기 [Article Type] Short Communication
[DOI] 10.3126/nje.v11i1.35659 PMC 바로가기 [Article Type] Short Communication